Rapafusyn

R&D

Partner Content

Baltimore, MD – February 5, 2024 – Rapafusyn proudly announces the distinguished recognition of Dr.

News

The B-Well trials of GSK's bepirovirsen position the antisense drug as a "major step towards a cure for hepatitis B infection," according to experts.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.